Company: SXTPW
Filing Date: 2025-09-02
Form Type: DEFR14A
Source: 0001213900-25-082789
Chunk: 42

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-09-02
Form: DEFR14A
Chunk 42
---
 of exercise. Stock Appreciation Rights A recipient does not recognize any taxable income upon the receipt of a stock appreciation right (“SAR”). Upon the exercise of a SAR, the recipient will recognize ordinary income in an amount equal to the excess of the fair market value of the underlying shares of common stock on the exercise date over the exercise price. Upon the exercise of a SAR, the Company will be entitled to a corresponding income tax deduction in the tax year in which the SAR was exercised. Equity Plan Information The following chart reflects the number of securities granted under equity compensation plans approved and not approved by stockholders and the weighted average exercise price for such plans as of December 31, 2024:

| 2022 Equity Incentive Plan:                                |     | Number                                                                                                      
 of securities to be issued upon exercise or issuance of outstanding options, units, warrants and rights(1): |       |     | Weighted                                                                
 average exercise price of outstanding options, warrants and rights(1) : |        |     | Number                                                    
 of securities remaining available for future issuance(1): |         |
|:-----------------------------------------------------------|:----|:------------------------------------------------------------------------------------------------------------|------:|:----|:------------------------------------------------------------------------|-------:|:----|:----------------------------------------------------------|--------:|
| Equity compensation plans approved by security holders     |     |                                                                                                             | 4,437 |     | $                                                                       | 116.07 |     |                                                           | 154,392 |
| Equity compensation plans not approved by security holders |     |                                                                                                             |     — |     |                                                                         |      — |     |                                                           |       — |
| Total                                                      |     |                                                                                                             | 4,437 |     | $                                                                       | 116.07 |     |                                                           | 154,392 |

| (1) | Balances presented as of December 31, 2024 |

The Board recommends that you vote “FOR” the approval to increase the total number of authorized shares
under the 2022 Equity Incentive Plan by 250,000 shares. 29 PROPOSAL 3 TO APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT OF OUR COMMON STOCK AT A REVERSE STOCK SPLIT RATIO RANGING FROM 1:3 TO 1:10, INCLUSIVE, AS DETERMINED BY THE BOARD IN ITS SOLE DISCRETION (Item 3 on the Proxy Card) Our stockholders are being asked to approve an amendment to